Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela A Guzzetta

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Surgical Research|May 12, 2012
Epithelioid sarcoma: one institution's experience with a rare sarcomaAngela A Guzzetta, Elizabeth A Montgomery, Heather Lyu, et al.
International Journal of Cancer|October 16, 2012
KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinomaTao Fu, Angela A Guzzetta, Jana Jeschke, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2012
DNA methylation biomarker candidates for early detection of colon cancerJoo Mi Yi, Mashaal Dhir, Angela A Guzzetta, et al.
Epigenetics|February 13, 2014
CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomasLifeng Sun, Angela A Guzzetta, Tao Fu, et al.
Plos One|April 27, 2017
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cellsAnup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Surgical Endoscopy|November 3, 2025
Comparative effectiveness of two simulation-based mastery learning robotic curricula in surgical education: a six-year experienceRicardo E Nunez-Rocha, Samy Castillo-Flores, Sofía Garcés Palacios, et al.
Plos One|November 30, 2020
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cellsAnup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosisTao Fu, Emmanouil P Pappou, Angela A Guzzetta, et al.
Annals of Surgery|March 31, 2015
IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal CancersTao Fu, Emmanouil P Pappou, Angela A Guzzetta, et al.
Journal of Surgical Oncology|April 15, 2016
Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic featuresEihab Abdelfatah, Angela A Guzzetta, Neeraja Nagarajan, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Surgical Research|May 12, 2012
Epithelioid sarcoma: one institution's experience with a rare sarcomaAngela A Guzzetta, Elizabeth A Montgomery, Heather Lyu, et al.
International Journal of Cancer|October 16, 2012
KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinomaTao Fu, Angela A Guzzetta, Jana Jeschke, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2012
DNA methylation biomarker candidates for early detection of colon cancerJoo Mi Yi, Mashaal Dhir, Angela A Guzzetta, et al.
Epigenetics|February 13, 2014
CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomasLifeng Sun, Angela A Guzzetta, Tao Fu, et al.
Plos One|April 27, 2017
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cellsAnup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Surgical Endoscopy|November 3, 2025
Comparative effectiveness of two simulation-based mastery learning robotic curricula in surgical education: a six-year experienceRicardo E Nunez-Rocha, Samy Castillo-Flores, Sofía Garcés Palacios, et al.
Plos One|November 30, 2020
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cellsAnup Sharma, Rajita Vatapalli, Eihab Abdelfatah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosisTao Fu, Emmanouil P Pappou, Angela A Guzzetta, et al.
Annals of Surgery|March 31, 2015
IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal CancersTao Fu, Emmanouil P Pappou, Angela A Guzzetta, et al.
Journal of Surgical Oncology|April 15, 2016
Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic featuresEihab Abdelfatah, Angela A Guzzetta, Neeraja Nagarajan, et al.
Pageof 3